Volume | 81,608 |
|
|||||
News | - | ||||||
Day High | 1.4366 | Low High |
|||||
Day Low | 1.36 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Milestone Pharmaceuticals Inc | MIST | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.43 | 1.36 | 1.4366 | 1.41 | 1.43 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
400 | 81,608 | US$ 1.39 | US$ 113,567 | - | 1.33 - 3.95 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 274 | US$ 1.41 | USD |
Milestone Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
46.88M | 33.48M | - | 1M | -59.69M | -1.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Milestone Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
5/29/2024 | 06:09 | Edgar (US Regulatory) | Form 8-K - Current report |
5/22/2024 | 07:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Partners with Arrhythmia Alliance.. |
5/13/2024 | 06:34 | Edgar (US Regulatory) | Form 8-K - Current report |
5/13/2024 | 05:59 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
3/04/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
3/01/2024 | 15:52 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2/29/2024 | 06:00 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Pricing of $30.0 Million.. |
2/28/2024 | 15:37 | GlobeNewswire Inc. | Milestone Pharmaceuticals Announces Proposed Public Offering.. |
2/26/2024 | 06:06 | Edgar (US Regulatory) | Form 8-K - Current report |
2/14/2024 | 19:56 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/14/2024 | 06:10 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
12/26/2023 | 07:54 | Dow Jones News | Milestone Pharmaceuticals Shares Sink 24% After Receiving.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIST Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.4806 | 1.4806 | 1.36 | 1.45 | 108,330 | -0.0706 | -4.77% |
1 Month | 1.75 | 1.78 | 1.36 | 1.60 | 230,140 | -0.34 | -19.43% |
3 Months | 1.56 | 1.98 | 1.36 | 1.67 | 190,646 | -0.15 | -9.62% |
6 Months | 2.59 | 2.93 | 1.33 | 1.75 | 303,557 | -1.18 | -45.56% |
1 Year | 3.88 | 3.95 | 1.33 | 2.13 | 217,667 | -2.47 | -63.66% |
3 Years | 5.50 | 9.8465 | 1.33 | 4.39 | 189,318 | -4.09 | -74.36% |
5 Years | 21.03 | 27.73 | 1.33 | 6.41 | 493,966 | -19.62 | -93.30% |
Milestone Pharmaceuticals Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. |